Global elimination of lymphatic filariasis

被引:9
作者
Ndeffo-Mbah, Martial L. [1 ]
Galvani, Alison P. [1 ]
机构
[1] Yale Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, New Haven, CT 06510 USA
关键词
GEOGRAPHIC-DISTRIBUTION; PROGRAM; IMPACT;
D O I
10.1016/S1473-3099(16)30544-8
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:358 / 359
页数:3
相关论文
共 12 条
[1]  
Irvine MA, 2016, LANCET INFECT DIS
[2]   What Is Needed to Eradicate Lymphatic Filariasis? A Model-Based Assessment on the Impact of Scaling Up Mass Drug Administration Programs [J].
Kastner, Randee J. ;
Stone, Christopher M. ;
Steinmann, Peter ;
Tanner, Marcel ;
Tediosi, Fabrizio .
PLOS NEGLECTED TROPICAL DISEASES, 2015, 9 (10)
[3]   Progress and Impact of 13 Years of the Global Programme to Eliminate Lymphatic Filariasis on Reducing the Burden of Filarial Disease [J].
Ramaiah, K. D. ;
Ottesen, Eric A. .
PLOS NEGLECTED TROPICAL DISEASES, 2014, 8 (11)
[4]   Can Lymphatic Filariasis Be Eliminated by 2020? [J].
Rebollo, Maria P. ;
Bockarie, Moses J. .
TRENDS IN PARASITOLOGY, 2017, 33 (02) :83-92
[5]   Toward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame [J].
Rebollo, Maria P. ;
Bockarie, Moses J. .
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2013, 11 (07) :723-731
[6]   Modelling the health impact and cost-effectiveness of lymphatic filariasis eradication under varying levels of mass drug administration scale-up and geographic coverage [J].
Stone, Christopher M. ;
Kastner, Randee ;
Steinmann, Peter ;
Chitnis, Nakul ;
Tanner, Marcel ;
Tediosi, Fabrizio .
BMJ GLOBAL HEALTH, 2016, 1 (01)
[7]   Lymphatic filariasis and onchocerciasis [J].
Taylor, Mark J. ;
Hoerauf, Achim ;
Bockarie, Moses .
LANCET, 2010, 376 (9747) :1175-1185
[8]   Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis [J].
Thomsen, Edward K. ;
Sanuku, Nelly ;
Baea, Manasseh ;
Satofan, Samson ;
Maki, Elit ;
Lombore, Bart ;
Schmidt, Mark S. ;
Siba, Peter M. ;
Weil, Gary J. ;
Kazura, James W. ;
Fleckenstein, Lawrence L. ;
King, Christopher L. .
CLINICAL INFECTIOUS DISEASES, 2016, 62 (03) :334-341
[9]  
WHO, 2016, WKLY EPIDEMIOL REC, V39, P441
[10]  
World Health Organization, 2010, GLOB PROGR EL LYMPH